Skip to main content
Top
Published in: The European Journal of Health Economics 5/2015

01-06-2015 | Editorial

Is personalized medicine a panacea for health management? Some thoughts on its desirability

Authors: Fernando Antoñanzas, Carmelo A. Juárez-Castelló, Roberto Rodríguez-Ibeas

Published in: The European Journal of Health Economics | Issue 5/2015

Login to get access

Excerpt

During the last decade we have witnessed a change in health care management. Predictive, personalized [1], individualized [2] or stratified [3] medicine are some of the terms that have been coined to describe a new approach to dealing with disease. In essence, the new paradigm is based on matching patients with the best treatments available according to each patient’s characteristics. Patients are classified through new tests, mainly genetic in nature, the growing proliferation of which is behind the extensive application of this new approach to managing disease. In parallel, new therapies, many based on new mechanisms of action and biological agents, allow ever narrower targets within the cell to be addressed. This combination of new diagnostic techniques and targeted therapies has improved the perspectives of managing some difficult conditions, such as some types of cancer, by controlling the progression of a disease and maintaining it rather as a chronic condition, even achieving a cure in some cases. This new paradigm is raising expectations for both patients and physicians. Health care systems are transforming the management of some diseases and re-writing treatment guidelines to incorporate the advantages of newly available therapies and approaches. However, notwithstanding the rapid development of these changes, there are some issues that should also be taken into account. Here, we highlight some elements that are frequently overlooked or taken for granted. …
Literature
1.
go back to reference Rogowski, W., Payne, K., Schnell-Inderst, P., Manca, A., Rochau, U., Jahn, B., Alagoz, O., Leidl, R., Siebert, U.: Concepts of ‘‘Personalization’’ in personalized medicine: implications for economic evaluation. PharmacoEconomics (2014). doi:10.1007/s40273-014-0211-5 PubMed Rogowski, W., Payne, K., Schnell-Inderst, P., Manca, A., Rochau, U., Jahn, B., Alagoz, O., Leidl, R., Siebert, U.: Concepts of ‘‘Personalization’’ in personalized medicine: implications for economic evaluation. PharmacoEconomics (2014). doi:10.​1007/​s40273-014-0211-5 PubMed
2.
go back to reference Hatz, M.H.M., Schremser, K., Rogowski, W.H.: Is individualized medicine more cost-effective? A systematic review. Pharmaco. Economics 32, 443–455 (2014)CrossRefPubMed Hatz, M.H.M., Schremser, K., Rogowski, W.H.: Is individualized medicine more cost-effective? A systematic review. Pharmaco. Economics 32, 443–455 (2014)CrossRefPubMed
3.
go back to reference Trusheim, M.R., Berndt, E.R., Douglas, F.L.: Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 6, 28793 (2007)CrossRef Trusheim, M.R., Berndt, E.R., Douglas, F.L.: Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 6, 28793 (2007)CrossRef
4.
go back to reference Antoñanzas, F., Rodríguez-Ibeas, R., Hutter, M.F., Lorente, R., Juárez, C., Pinillos, M.: Genetic testing in the European Union: does economic evaluation matter? Eur J Health Econ 12(5), 651–662 (2012)CrossRef Antoñanzas, F., Rodríguez-Ibeas, R., Hutter, M.F., Lorente, R., Juárez, C., Pinillos, M.: Genetic testing in the European Union: does economic evaluation matter? Eur J Health Econ 12(5), 651–662 (2012)CrossRef
5.
Metadata
Title
Is personalized medicine a panacea for health management? Some thoughts on its desirability
Authors
Fernando Antoñanzas
Carmelo A. Juárez-Castelló
Roberto Rodríguez-Ibeas
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 5/2015
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0665-6

Other articles of this Issue 5/2015

The European Journal of Health Economics 5/2015 Go to the issue